-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: DeneciMIG showed good tolerability after switching from ecurizumab.

智通财经·09/17/2026 11:09:10
语音播报
Novo Nordisk: DeneciMIG showed good tolerability after switching from ecurizumab.